← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #690 OF 1,000 MOST-CITED

Instruments, apparatus, et. al. not meeting specs

FDA cited this observation 24 times across 24 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs24
BY FISCAL YEAR
FY20261
FY20251
FY20242
FY20231
FY20222
FY20201
FY20195
FY20188
FY20173

How FDA worded it — real examples

The use of instruments not meeting established specifications was observed.

Westwood Laboratories, LLC. · Azusa, California · Drugs · 2026-03-26

The use of instruments and apparatus not meeting established specifications was observed.

Salvona Technologies, LLC · Hamilton, New Jersey · Drugs · 2024-10-18

The use of instruments, apparatus and recording devices not meeting established specifications was observed.

Landy International · Xia Men · Drugs · 2023-12-14

The use of instruments, apparatus and recording devices not meeting established specifications was observed.

Dr. Reddy's Laboratories Ltd. · Medchal-Malkajgiri District · Drugs · 2023-10-27

The use of instruments and recording devices not meeting established specifications was observed.

Aesthetic Plus Company Limited · Sam Phran · Drugs · 2023-09-15

The use of instruments and recording devices not meeting established specifications was observed.

KVK Tech, Inc. · Newtown, Pennsylvania · Drugs · 2022-07-08

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →